A Phase III readout in September 2024 for rocatinlimab, on which Amgen and Kyowa Kirin were collaborating in atopic dermatitis, appeared underwhelming to analysts, with Jefferies noting that the data ...
6don MSN
Residents of a polluted California town pinned hopes on new state rules. They’re still waiting
A 2015 law required the state Department of Toxic Substances Control to overhaul its permitting process to consider how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results